SYNTHETIC BIOLOG INC has a total of 18 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are AU JESSIE L S, ALVINE PHARMACEUTICALS INC and NORDIC VACCINE TECHNOLOGY AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | China | 3 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Fermentation | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kaleko Michael | 10 |
#2 | Connelly Sheila | 8 |
#3 | Koski Pertti | 6 |
#4 | Bristol Andrew | 4 |
#5 | Airaksinen Ulla | 4 |
#6 | Valimaki Katja | 3 |
#7 | Newsome David A | 2 |
#8 | Crouch Dennis | 2 |
#9 | Kaeaeriaeinen Susanna | 2 |
#10 | Brewer George J | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016073562A1 | Methods and compositions for inhibiting clostridium difficile | |
CN106163546A | There is the beta lactamase of the therapeutic properties of improvement |